2012
DOI: 10.1002/ccd.24479
|View full text |Cite
|
Sign up to set email alerts
|

Transcatheter aortic valve implantation for severe regurgitation in native and degenerated bioprosthetic aortic valves

Abstract: TAVI with the CRS bioprosthesis is feasible and effective in appropriately selected cases of severe aortic regurgitation in native and bioprosthetic aortic valves.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
12
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 17 publications
1
12
0
Order By: Relevance
“…There have been multiple reports of complications of the procedure, including access issues (3133), aortic root trauma (3436), malpositioning of the THV (3739), coronary obstruction (40,41), paravalvular regurgitation (PAR) (4249), ventricular septal or mitral leaflet perforation (35), and cardiogenic shock (50,51). This imaging compendium from the PARTNER trials is intended to be a comprehensive compilation of intraprocedural complications imaged by using intraprocedural TEE and diagnostic tools to anticipate and/or prevent their occurrence.…”
mentioning
confidence: 99%
“…There have been multiple reports of complications of the procedure, including access issues (3133), aortic root trauma (3436), malpositioning of the THV (3739), coronary obstruction (40,41), paravalvular regurgitation (PAR) (4249), ventricular septal or mitral leaflet perforation (35), and cardiogenic shock (50,51). This imaging compendium from the PARTNER trials is intended to be a comprehensive compilation of intraprocedural complications imaged by using intraprocedural TEE and diagnostic tools to anticipate and/or prevent their occurrence.…”
mentioning
confidence: 99%
“…The authors published the first successful series of TAVR in severe native AR (Aortic Regurgitation). 25 A recent multicenter registry 26 examined outcomes after TAVR for AR. It demonstrated a lower success rate and increased 30-day and 1-year mortality for patients who underwent TAVR for AR versus AS.…”
Section: Ongoing Trials With Transcatheter Aortic Valve Replacementmentioning
confidence: 99%
“…The main advantage of this method is the reduced invasiveness for the patient, as the need for cardiopulmonary bypass is eliminated and the procedure results in faster recovery (Walther et al , ) and better haemodynamic performance than surgically implanted stented valves (Clavel et al , ). Taking into consideration the advantages associated with TAVI, this technique is currently offered not only to inoperable or high‐risk patients (Sarkar et al , ), but also to those with fewer contraindications to surgery (Tamburino et al , ), and the results obtained in the intermediate‐risk patient cohort are comparable to the surgical replacement (Leon et al , ).…”
Section: Heart Valve Implantation Proceduresmentioning
confidence: 99%